National Jewish Health clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
3 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 2 with minor changes only.
- Minor: PREDICT-HP · Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis Trial completed
- Minor: Omalizumab in the Skin of Food Allergy Patients Primary completion date changed from estimate of Sep 2026 to Nov 3, 2026
- Notable: Enhancing Hypnotic Medication Discontinuation in Primary Care Enrollment reduced: 430 → 250 participants
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 1 | |
| Phase 1/2 | 1 | |
| Phase 2 | 2 | |
| Phase 3 | 1 | |
| Phase 4 | 1 |
Not charted: 10 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Asthma (4) · Idiopathic Pulmonary Fibrosis (2) · COPD (1) · Cystic Fibrosis (1) · Lupus (SLE) (1)
Get alerts when National Jewish Health's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.